Abu S Shamsuzzaman1,2,3, Virend K Somers3, Timothy K Knilans2, Michael J Ackerman3,4, Yu Wang5, Raouf S Amin1,2. 1. Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 2. Department of Pediatrics, University of Cincinnati, Cincinnati, OH. 3. Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN. 4. Departments of Pediatrics and Molecular Pharmacology and Experimental Therapeutics; Division of Pediatric Cardiology; Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN. 5. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Abstract
BACKGROUND: Congenital long QT syndrome (LQTS) is a familial arrhythmogenic cardiac channelopathy characterized by prolonged ventricular repolarization and increased risk of torsades de pointes-mediated syncope, seizures, and sudden cardiac death (SCD). QT prolongation corrected for heart rate (QTc) is an important diagnostic and prognostic feature in LQTS. Obstructive sleep apnea (OSA) has been increasingly implicated in the pathogenesis of cardiovascular disease, including arrhythmias and SCD. We tested the hypothesis that the presence of concomitant OSA in patients with LQTS is associated with increased QT intervals, both during sleep and while awake. METHODS AND RESULTS: Polysomnography with simultaneous overnight 12-lead electrocardiography (ECG) was recorded in 54 patients with congenital LQTS and 67 control subjects. OSA was diagnosed as apnea-hypopnea index (AHI) ≥ 5 events/h for adults and AHI > 1 event/h for children. RR and QT intervals were measured from the 12-lead surface ECG. QTc was determined by the Bazett formula. Respiratory disturbance index, AHI, and arousal index were significantly increased in patients with LQTS and with OSA compared to those without OSA and control subjects. QTc during different sleep stages and while awake was also significantly increased in patients with LQTS and OSA compared to those without OSA. Severity of OSA in patients with LQTS was directly associated with the degree of QTc. CONCLUSIONS: The presence and severity of obstructive sleep apnea (OSA) in patients with congenital long QT syndrome (LQTS) is associated with increased QT prolongation corrected for heart rate, which is an important biomarker of sudden cardiac death (SCD). Treatment of OSA in LQTS patients may reduce QT prolongation, thus reducing the risk of LQT-triggered SCD.
BACKGROUND:Congenital long QT syndrome (LQTS) is a familial arrhythmogenic cardiac channelopathy characterized by prolonged ventricular repolarization and increased risk of torsades de pointes-mediated syncope, seizures, and sudden cardiac death (SCD). QT prolongation corrected for heart rate (QTc) is an important diagnostic and prognostic feature in LQTS. Obstructive sleep apnea (OSA) has been increasingly implicated in the pathogenesis of cardiovascular disease, including arrhythmias and SCD. We tested the hypothesis that the presence of concomitant OSA in patients with LQTS is associated with increased QT intervals, both during sleep and while awake. METHODS AND RESULTS: Polysomnography with simultaneous overnight 12-lead electrocardiography (ECG) was recorded in 54 patients with congenital LQTS and 67 control subjects. OSA was diagnosed as apnea-hypopnea index (AHI) ≥ 5 events/h for adults and AHI > 1 event/h for children. RR and QT intervals were measured from the 12-lead surface ECG. QTc was determined by the Bazett formula. Respiratory disturbance index, AHI, and arousal index were significantly increased in patients with LQTS and with OSA compared to those without OSA and control subjects. QTc during different sleep stages and while awake was also significantly increased in patients with LQTS and OSA compared to those without OSA. Severity of OSA in patients with LQTS was directly associated with the degree of QTc. CONCLUSIONS: The presence and severity of obstructive sleep apnea (OSA) in patients with congenital long QT syndrome (LQTS) is associated with increased QT prolongation corrected for heart rate, which is an important biomarker of sudden cardiac death (SCD). Treatment of OSA in LQTS patients may reduce QT prolongation, thus reducing the risk of LQT-triggered SCD.
Authors: R H Ali; W Zareba; A J Moss; P J Schwartz; J Benhorin; G M Vincent; E H Locati; S Priori; C Napolitano; J A Towbin; W J Hall; J L Robinson; M L Andrews; L Zhang; K Timothy; A Medina Journal: Am J Cardiol Date: 2000-02-15 Impact factor: 2.778
Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188
Authors: Kristina H Haugaa; J Martijn Bos; Robert F Tarrell; Bruce W Morlan; Pedro J Caraballo; Michael J Ackerman Journal: Mayo Clin Proc Date: 2013-04 Impact factor: 7.616
Authors: Paola A Lanfranchi; Abu S M Shamsuzzaman; Michael J Ackerman; Tomas Kara; Pavel Jurak; Robert Wolk; Virend K Somers Journal: Circulation Date: 2002-09-17 Impact factor: 29.690
Authors: N Wang; H S Kang; G Ahmmed; S A Khan; V V Makarenko; N R Prabhakar; J Nanduri Journal: Am J Physiol Cell Physiol Date: 2015-12-09 Impact factor: 4.249
Authors: Karan R Chadda; Ibrahim T Fazmin; Shiraz Ahmad; Haseeb Valli; Charlotte E Edling; Christopher L-H Huang; Kamalan Jeevaratnam Journal: Sleep Date: 2018-09-01 Impact factor: 5.849